These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6276000)

  • 1. Clinical evaluation of cefotaxime in the treatment of purulent meningitis in children.
    Kobayashi Y; Morikawa Y; Haruta T; Fujii R; Meguro H; Hori M; Kurosu Y; Toyonaga Y; Iwai N; Kitamura I; Hamawaki M; Ozaki H; Nishimura T
    Clin Ther; 1981; 4 Suppl A():89-110. PubMed ID: 6276000
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of purulent meningitis with ceftriaxone].
    Guggenbichler JP; Parth J
    Wien Med Wochenschr Suppl; 1985; 87():12-6. PubMed ID: 3856970
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic management of purulent meningitis in children. Report of 101 cases].
    Arch Fr Pediatr; 1990; 47(7):491-5. PubMed ID: 2256787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of cefotaxime in the treatment of purulent meningitis in children.
    Kobayashi Y; Morikawa Y; Haruta T; Fujii R; Meguro H; Hori M; Kurosu Y; Toyonaga Y; Iwai N; Kitamura I; Hamawaki M; Ozaki H
    Jpn J Antibiot; 1981 Jun; 34(6):946-54. PubMed ID: 6270420
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cefotaxim--an alternative in the treatment of purulent meningitis in children?].
    Helwig H; Daschner F
    Dtsch Med Wochenschr; 1982 Sep; 107(36):1343-6. PubMed ID: 6288338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cefotaxime in the therapy of purulent meningitis in childhood].
    Bozinović D; Dvorzak I; Kuzmanović N; Grljusić V
    Lijec Vjesn; 1987 Oct; 109(10):391-6. PubMed ID: 3669882
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cefotaxime in the treatment of purulent meningitis].
    Kepp BT; Friis-Møller A; Kristensen HS; Jessen O; Høiby N
    Ugeskr Laeger; 1986 Apr; 148(16):954-7. PubMed ID: 3727049
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacokinetics of ceftriaxone in blood and ventricular cerebrospinal fluid in children with ventriculitis].
    Prado V; Arancibia A; Aguirre X
    Bol Med Hosp Infant Mex; 1984 Jun; 41(6):313-7. PubMed ID: 6089848
    [No Abstract]   [Full Text] [Related]  

  • 9. Initial treatment of purulent meningitis in infants 1 to 3 months of age.
    Kovacs JE; Ryan ME
    J Am Osteopath Assoc; 1987 Aug; 87(8):566-8. PubMed ID: 3312128
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetics and clinical evaluation of cefotaxime in children suffering with purulent meningitis.
    Bégué P; Floret D; Mallet E; Raynaud EJ; Safran C; Sarlangues J; Teyssier G
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():161-5. PubMed ID: 6094436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Empirical treatment of purulent meningitis].
    Löpez de Munain A; García-Arenzana JM
    Enferm Infecc Microbiol Clin; 1990; 8(7):464-5. PubMed ID: 2152491
    [No Abstract]   [Full Text] [Related]  

  • 12. Cefotaxime treatment of meningitis in children.
    Sow A
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():191-4. PubMed ID: 6094439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Initial treatment of purulent meningitis by cefotaxime. Apropos of 27 cases].
    Bertrand JL; Peyramond D; Godard J; La Selve H; Woehrle R
    Rev Med Interne; 1983 Dec; 4(4):373-8. PubMed ID: 6320324
    [No Abstract]   [Full Text] [Related]  

  • 14. Single-dose plasma and cerebrospinal fluid pharmacokinetics of ceftriaxone in infants and children.
    Reed MD; Rekate HL; Aronoff SC; Myers CM; Blumer JL
    Clin Pharm; 1983; 2(6):558-63. PubMed ID: 6317277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of staphylococci in the etiology of purulent meningitis].
    Proskurov VA
    Voen Med Zh; 1970 Oct; 10():32-4. PubMed ID: 5507584
    [No Abstract]   [Full Text] [Related]  

  • 16. Carbapenem treatment of meningitis.
    Klugman KP; Dagan R
    Scand J Infect Dis Suppl; 1995; 96():45-8. PubMed ID: 7652503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug of choice for meningitis.
    Helwig H
    Pediatr Infect Dis J; 1987 Jan; 6(1):86. PubMed ID: 3822629
    [No Abstract]   [Full Text] [Related]  

  • 18. [Importance of the cefotaxime-fosfomycin combination. Apropos of a case of meningitis due to heterogeneously resistant Staphylococcus aureus].
    Tremeaux JC; Duez JM; Pechinot A; Sautreaux JL; Thierry A; Kazmierczak A
    Agressologie; 1983 Apr; 24(4):169-71. PubMed ID: 6314832
    [No Abstract]   [Full Text] [Related]  

  • 19. [Course of ampicillin sensitivity in Haemophilus influenzae responsible for purulent meningitis in children. Therapeutic consequences].
    Joly C; Bouillie C; Hummel M; Lionsquy G
    Pathol Biol (Paris); 1983 May; 31(5):304-7. PubMed ID: 6312391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Enterobacteriaceae meningitis treated with cefotaxime].
    Guerrero A; Pérez-Gorricho B; Loza E; Ludeña-Carpio MC; Bustos JC; Bouza E
    Rev Clin Esp; 1986 Apr; 178(7):319-21. PubMed ID: 3738001
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.